Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?

Nephrology

Volumn 11, Issue 5, 2006, Pages 394-399

  Diskin, Charles J ^a   Stokes, Thomas J ^a   Dansby, Linda M ^a   Radcliff, Lautrec ^a   Carter, Thomas B ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Acidosis; Anaemia; Erythropoietin; Haemodialysis; Oxygen dissociation; Phosphorus

Indexed keywords

BICARBONATE; PARATHYROID HORMONE; PHOSPHORUS; RECOMBINANT ERYTHROPOIETIN; UREA;

ACIDOSIS; ADULT; AGE DISTRIBUTION; BICARBONATE BLOOD LEVEL; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRY WEIGHT; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FAILURE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OXYGEN CONSUMPTION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; TWO TAILED TEST;

ACIDOSIS, RENAL TUBULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; DOWN-REGULATION; DRUG RESISTANCE; ERYTHROPOIETIN; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXYGEN; PHOSPHATES; PHOSPHORUS METABOLISM DISORDERS; RECEPTORS, ERYTHROPOIETIN; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 33749126300     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00674.x     Document Type: Review

References (24)

1. Van Wyck DB, Stivelman JC, Ruiz J, Kirlin LF, Katz MA, Ogden DA. Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int. 1989; 35: 712-16.
2. Eschbach JW. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989; 35: 134-48.
3. Lacombe C. Resistance to erythropoietin. N. Engl. J. Med. 1996; 334: 660-62.
4. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N. Engl. J. Med. 1996; 334: 420-25.
5. Schreiber S, Howaldt S, Schnoor M et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N. Engl J. Med. 1996; 334: 619-23.
6. Rio DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N. Engl. J. Med. 1993; 328: 171-5.
7. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N. Engl. J. Med. 1996; 334: 630-33.
8. Diskin CJ, Jones KLO. Erythropoietin Levels in ESRD by Enzyme Immunoassay. Kidney Int. 1985; 27: 160A.
9. Rossert J, Eckardt KU. Erythropoietin receptors: Their role beyond erythropoiesis. Nephrol. Dial. Transplant. 2005; 20: 1025-8.
10. Arcasoy MO, Amin K, Chou SC, Haroon ZA, Varia M, Raleigh JA. Erythropoietin and erythropoietin receptor expression in head and neck cancer: Relationship to tumor hypoxia. Clin. Cancer Res. 2005; 11: 20-27.
11. Ershler WB, Sheng S, McKelvey J et al. Serum erythropoietin and aging: A longitudinal analysis. J. Am. Geriatr. Soc. 2005; 53: 1360-65.
12. Relman AS. Renal acidosis and renal excretion of acid in health and disease. Adv. Intern. Med. 1964; 12: 295-347.
13. Movilli E, Feliciani A, Camerini C et al. High calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. Nephron Clin. Pract. 2005; 101: c161-7.
14. Schuck O, Kaslikov J. Kinetics of phosphorus during hemodialysis and the calculation of its effective dialysis clearance. Clin. Nephrol. 1997; 47: 379-83.
15. Monti JP, Baz M, Klinkmann H, Elsen R, Berland Y, Crevat A. Adaptation of uremic patients to anemia; a 31P nuclear magnetic resonance study. Nephrol. Dial. Transplant. 1990; 5: 604-7.
16. Monti JP, Brunet P, Baz M et al. 2,3 diphosphoglycerate-haemoglobin binding in uraemic patients treated with erythropoietin. A 31P-nuclear magnetic resonance study. Nephrol. Dial. Transplant. 1993; 8: 223-6.
17. Benesch R, Benesch RE. Intracellular organic phosphates as regulators of oxygen release by haemoglobin. Nature 1969; 221: 618-22.
18. Chanutin A, Hermann E. The interaction of organic and inorganic phosphates with hemoglobin. Arch. Biochem. Biophys. 1969; 131: 180-84.
19. Goodman J, Bessman AN. Effect of hemodialysis on red cell organic and inorganic phosphates. Am. J. Med. Sci. 1975; 270: 447-51.
20. Yoshimura A, Arai K. Physician education: The erythropoietin receptor signal transduction. Oncologist 1996; 1: 337-9.
21. Beckman DL, Lin LL, Quinones ME, Longmore GD. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. Blood 1999; 94: 2667-75.
22. Winter SS, Howard T, Ware RE. Regulation of expression of the human erythropoietin receptor gene. Blood Cells Mol. Dis. 1996; 22: 214-24.
23. Najjar SS, Bottomley PA, Schulman SP et al. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease. J. Cardiovasc Magn. Reson. 2005; 7: 657-66.
24. Hamilton C, Steinlechner B, Gruber E, Simon P, Wollenek G. The oxygen dissociation curve: Quantifying the shift. Perfusion 2004; 19: 141-4.